<HashMap><database>biostudies-other</database><scores/><additional><submitter>Ndjamen B</submitter><funding>Howard Hughes Medical Institute</funding><funding>NIAID NIH HHS</funding><pagination>e1003961</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3946383</full_dataset_link><abstract>The Herpes Simplex Virus 1 (HSV-1) glycoprotein gE-gI is a transmembrane Fc receptor found on the surface of infected cells and virions that binds human immunoglobulin G (hIgG). gE-gI can also participate in antibody bipolar bridging (ABB), a process by which the antigen-binding fragments (Fabs) of the IgG bind a viral antigen while the Fc binds to gE-gI. IgG Fc binds gE-gI at basic, but not acidic, pH, suggesting that IgG bound at extracellular pH by cell surface gE-gI would dissociate and be degraded in acidic endosomes/lysosomes if endocytosed. The fate of viral antigens associated with gE-gI-bound IgG had been unknown: they could remain at the cell surface or be endocytosed with IgG. Here, we developed an in vitro model system for ABB and investigated the trafficking of ABB complexes using 4-D confocal fluorescence imaging of ABB complexes with transferrin or epidermal growth factor, well-characterized intracellular trafficking markers. Our data showed that cells expressing gE-gI and the viral antigen HSV-1 gD endocytosed anti-gD IgG and gD in a gE-gI-dependent process, resulting in lysosomal localization. These results suggest that gE-gI can mediate clearance of infected cell surfaces of anti-viral host IgG and viral antigens to evade IgG-mediated responses, representing a general mechanism for viral Fc receptors in immune evasion and viral pathogenesis.</abstract><repository>biostudies-other</repository><data_source>Europe PMC</data_source><omics_type>Unknown</omics_type><volume>10(3)</volume><journal>PLoS pathogens</journal><pmcid>PMC3946383</pmcid><funding_grant_id>R01 AI041239</funding_grant_id><funding_grant_id>R37 AI041239</funding_grant_id><funding_grant_id>5R37 AI041239-15</funding_grant_id><pubmed_authors>Ndjamen B</pubmed_authors><pubmed_authors>Bjorkman PJ</pubmed_authors><pubmed_authors>Farley AH</pubmed_authors><pubmed_authors>Lee T</pubmed_authors><pubmed_authors>Fraser SE</pubmed_authors></additional><is_claimable>false</is_claimable><name>The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface.</name><description>The Herpes Simplex Virus 1 (HSV-1) glycoprotein gE-gI is a transmembrane Fc receptor found on the surface of infected cells and virions that binds human immunoglobulin G (hIgG). gE-gI can also participate in antibody bipolar bridging (ABB), a process by which the antigen-binding fragments (Fabs) of the IgG bind a viral antigen while the Fc binds to gE-gI. IgG Fc binds gE-gI at basic, but not acidic, pH, suggesting that IgG bound at extracellular pH by cell surface gE-gI would dissociate and be degraded in acidic endosomes/lysosomes if endocytosed. The fate of viral antigens associated with gE-gI-bound IgG had been unknown: they could remain at the cell surface or be endocytosed with IgG. Here, we developed an in vitro model system for ABB and investigated the trafficking of ABB complexes using 4-D confocal fluorescence imaging of ABB complexes with transferrin or epidermal growth factor, well-characterized intracellular trafficking markers. Our data showed that cells expressing gE-gI and the viral antigen HSV-1 gD endocytosed anti-gD IgG and gD in a gE-gI-dependent process, resulting in lysosomal localization. These results suggest that gE-gI can mediate clearance of infected cell surfaces of anti-viral host IgG and viral antigens to evade IgG-mediated responses, representing a general mechanism for viral Fc receptors in immune evasion and viral pathogenesis.</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Mar</publication><modification>2019-03-27T01:23:02Z</modification><creation>2019-03-27T01:23:02Z</creation></dates><accession>S-EPMC3946383</accession><cross_references><pubmed>24604090</pubmed><doi>10.1371/journal.ppat.1003961 </doi></cross_references></HashMap>